Clinical Trial Update: A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric) [Phase 1, Phase 2]

View source ↗

Summary

A pediatric clinical trial evaluating CNCT19, a CAR-T therapy, for relapsed/refractory B-cell acute lymphoblastic leukemia in children and adolescents; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CNCT19 (CNCT19 cell therapy)

Snippet

Sponsor: Juventas Cell Therapy Ltd. | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: RECRUITING